Kognitic Launches Covid-19 Insight Series

With over 1 million globally confirmed Covid-19 cases, the promise of bringing lives back to ‘normal’ seems ambiguous. Amidst several strategies to fight against the disease, steady increase in clinical trials listings offer a glimmer of hope. Today, Kognitic launches an insight series on Covid-19 clinical trials.

Below, we share some fundamental metrics associated with interventional clinical trials. As we plan to share deep insights on the trials in the upcoming weeks, please do comment your suggestions and recommendations.